N. Anderson
Director/Board Member at LUNA INNOVATIONS INCORPORATED
Net worth: 52 027 $ as of 2024-03-30
Profile
N.
Leigh Anderson was the founder of Large Scale Biology Corp.
(founded in 2001) where they served as the Chief Scientific Officer from 2001 to 2002.
They are also the founder of Siscapa Assay Technologies, Inc. (founded in 2011) where they currently hold the position of Chief Executive Officer since 2011.
Additionally, Dr. Anderson is the founder of The Plasma Proteome Institute (founded in 2002) where they serves as the Chief Executive Officer.
Dr. Anderson's current job(s) include being an Independent Director at Luna Innovations, Inc. since 2017 and being the Principal at Anderson Forschung Group LLC since 2002.
Dr. Anderson's former job(s) include being a Director at Dade Behring Holdings, Inc. from 2002 to 2007.
Dr. Anderson's education history includes a doctorate degree from the University of Cambridge and an undergraduate degree from Yale University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-05-23 | 16,233 ( 0.05% ) | 52 027 $ | 2024-03-30 |
N. Anderson active positions
| Companies | Position | Start |
|---|---|---|
| LUNA INNOVATIONS INCORPORATED | Director/Board Member | 2017-05-23 |
| The Plasma Proteome Institute | Chief Executive Officer | 2001-12-31 |
| Anderson Forschung Group LLC | Corporate Officer/Principal | 2001-12-31 |
Siscapa Assay Technologies, Inc.
 Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Siscapa Assay Technologies, Inc. provides products and services for precise quantitation of protein biomarkers, drugs, and drug targets using immuno-affinity mass spectrometry. Siscapa assays are used in clinical diagnostics and pharma R&D for particularly demanding applications, and in biomarker panels to characterize changes in health, disease, and treatment in longitudinal user-collected dried blood microsamples. Siscapa immuno-affinity mass spectrometry assays for targeted protein quantitation can be developed more quickly than typical ELISA immunoassays since they require only a single specific antibody and provide absolute target specificity because of the MS detection. Because Siscapa assays do not interact with one another, these assays can be freely assembled in panels for various applications. The American company was founded by N. Leigh Anderson, who has been the CEO since incorporation. | Chief Executive Officer | 2010-12-31 |
Former positions of N. Anderson
| Companies | Position | End |
|---|---|---|
Dade Behring Holdings, Inc.
 Dade Behring Holdings, Inc. Medical SpecialtiesHealth Technology Dade Behring Holdings, Inc. manufactures medical diagnostic equipment. It develops and markets equipment and consumable supplies and provides maintenance services to clinical laboratories to perform diagnostic tests. The company's customers include hospitals and reference laboratories. The company was founded in 1994 and is headquartered in Deerfield, IL. | Director/Board Member | 2006-12-31 |
Large Scale Biology Corp.
 Large Scale Biology Corp. BiotechnologyHealth Technology Large Scale Biology Corp. is a biotechnology company, which develops and manufactures recombinant biologics. Its products includes vaccines, complex proteins and follow-on off-patent therapeutics. It is located in Vacaville, CA. | Founder | 2001-12-31 |
Training of N. Anderson
| University of Cambridge | Doctorate Degree |
| Yale University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LUNA INNOVATIONS INCORPORATED | Electronic Technology |
| Private companies | 5 |
|---|---|
Large Scale Biology Corp.
Large Scale Biology Corp. BiotechnologyHealth Technology Large Scale Biology Corp. is a biotechnology company, which develops and manufactures recombinant biologics. Its products includes vaccines, complex proteins and follow-on off-patent therapeutics. It is located in Vacaville, CA. | Health Technology |
Dade Behring Holdings, Inc.
Dade Behring Holdings, Inc. Medical SpecialtiesHealth Technology Dade Behring Holdings, Inc. manufactures medical diagnostic equipment. It develops and markets equipment and consumable supplies and provides maintenance services to clinical laboratories to perform diagnostic tests. The company's customers include hospitals and reference laboratories. The company was founded in 1994 and is headquartered in Deerfield, IL. | Health Technology |
Siscapa Assay Technologies, Inc.
Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Siscapa Assay Technologies, Inc. provides products and services for precise quantitation of protein biomarkers, drugs, and drug targets using immuno-affinity mass spectrometry. Siscapa assays are used in clinical diagnostics and pharma R&D for particularly demanding applications, and in biomarker panels to characterize changes in health, disease, and treatment in longitudinal user-collected dried blood microsamples. Siscapa immuno-affinity mass spectrometry assays for targeted protein quantitation can be developed more quickly than typical ELISA immunoassays since they require only a single specific antibody and provide absolute target specificity because of the MS detection. Because Siscapa assays do not interact with one another, these assays can be freely assembled in panels for various applications. The American company was founded by N. Leigh Anderson, who has been the CEO since incorporation. | Health Technology |
| The Plasma Proteome Institute | |
| Anderson Forschung Group LLC |
- Stock Market
- Insiders
- N. Anderson
